View Older Stories View More Recent Stories

Mar 31, 2022 01:00PM Trevena (TRVN) PT Lowered to $2 at Cantor Fitzgerald
Mar 31, 2022 12:58PM Auxly Cannabis (XLY:CN) (CBWTF) PT Lowered to Cdn$0.21 at Cantor Fitzgerald
Mar 31, 2022 12:42PM Cutera (CUTR) PT Raised to $85 at Cantor Fitzgerald as AviClear Could Change Acne Paradigm
Mar 31, 2022 09:43AM Trulieve Cannabis Corp (TCNNF) PT Lowered to $59 at Cantor Fitzgerald
Mar 31, 2022 06:23AM Clarus (CRXT) PT Lowered to $3 at Cantor Fitzgerald
Mar 30, 2022 05:07PM Form 10-K Cantor Fitzgerald Income For: Dec 31
Mar 30, 2022 08:30AM Ric Kayne and Affiliates Confirm Nomination of Two Highly Qualified Candidates for Election to Athira Pharma’s Board of Directors
Mar 30, 2022 08:01AM Satellogic (SATL) Elects Tom Killalea to its Board of Directors
Mar 30, 2022 08:00AM Satellogic Elects Tom Killalea to its Board of Directors
Mar 30, 2022 06:19AM Cantor Fitzgerald Lowers PT to $5, Reiterates Overweight Rating on PAVmed (PAVM)
Mar 29, 2022 04:11PM PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
Mar 29, 2022 04:05PM Cantor Fitzgerald Starts Nerdy (NRDY) at Overweight
Mar 29, 2022 09:00AM Capricor Therapeutics to Participate in the Cantor Fitzgerald Rare Orphan Disease Summit
Mar 29, 2022 07:45AM Cantor Fitzgerald Reiterates Overweight Rating and $12 PT on Lucid Diagnostics (LUCD), "We Encourage Investors to Acquire LUCD Shares at Attractive Valuation"
Mar 29, 2022 06:32AM Jushi Holding (JUSHF) PT Lowered to $3.05 at Cantor Fitzgerald
Mar 29, 2022 05:55AM Cantor Fitzgerald Reiterates Overweight Rating on Fortress Biotech (FBIO), Sees Upward Earnings Revisions and Multiple Expansion
Mar 29, 2022 05:54AM Cantor Fitzgerald Reiterates Overweight Rating on Arcutis Biotherapeutics (ARQT)
Mar 28, 2022 04:50PM Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4
Mar 28, 2022 04:47PM Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
Mar 28, 2022 04:06PM UPDATE: Trulieve Cannabis Corp (TCNNF) PT Lowered to $60 at Cantor Fitzgerald
Mar 28, 2022 11:20AM Abeona Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Mar 28, 2022 11:20AM Abeona Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Mar 28, 2022 11:10AM UPDATE: HUTCHMED (China) (HCM) and Viatris (VTRS) Top Cantor Fitzgerald's List of Biggest Short Interest Increases, Heron (HRTX) and Omeros (OMER) Continue to Have Higher Short Floats
Mar 28, 2022 07:00AM Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit
Mar 25, 2022 08:00AM Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Mar 25, 2022 06:08AM Cantor Fitzgerald Reiterates Overweight Rating on Graybug Vision (GRAY) with $4 PT, Believes Stock Deserves Greater Attention from Investors
Mar 24, 2022 12:08PM Cantor Fitzgerald Reiterates ContraFect (CFRX) at Overweight with $15 PT, Expects Upwards Earnings Revisions
Mar 23, 2022 05:02PM Cantor Fitzgerald Reiterates Aspira Women’s Health (AWH) at Overweight with $4 PT, Sees Shares as "Materially Undervalued"
Mar 23, 2022 04:15PM DURECT Corporation To Present at the 2022 Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Mar 23, 2022 04:01PM Longboard Pharmaceuticals to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit
Mar 23, 2022 03:48PM Exela Technologies (XELA) PT Lowered to $2 at Cantor Fitzgerald
Mar 23, 2022 10:27AM Cantor Fitzgerald Reiterates Aytu Biosciences (AYTU) at Overweight, $11 PT, Sees it as Positive Development Potentially Extending ADHD Franchise Revenue Runway
Mar 23, 2022 09:55AM Cantor Fitzgerald Reiterates Overweight Rating on Lucid Diagnostics Inc (LUCD), Sees Launch in Three New Areas as Favorable and as an Important Commercialization Milestone
Mar 23, 2022 09:44AM Cantor Fitzgerald Reiterates Pfizer (PFE) at Overweight Rating with $75 PT on Phase 3 etrasimod Data
Mar 23, 2022 07:51AM Exagen (XGN) PT Lowered to $19 at Cantor Fitzgerald on Weaker Guidance, but Analyst Maintained Overweight Rating and Positive Outlook, "Would Encourage Investors to Acquire Shares" at Current Valuatio
Mar 23, 2022 07:30AM MariMed to Participate in April Investor Conferences
Mar 23, 2022 07:00AM Chemomab Therapeutics to Participate in Cantor Fitzgerald Rare Orphan Disease Summit
Mar 23, 2022 01:03AM Options mavens see stock rebound as chance to pick up downside protection
Mar 22, 2022 09:44PM Lanvin Group, a Global Luxury Fashion Group, to Become Publicly Traded on the NYSE via Business Combination with Primavera Capital Acquisition Corporation
Mar 22, 2022 08:45AM Applied Genetic Technologies (AGTC) Prices 7.5M Share Offering at $1.31/sh
Mar 22, 2022 08:45AM AGTC Announces Pricing of Public Offering of Common Stock
Mar 22, 2022 08:45AM AGTC Announces Pricing of Public Offering of Common Stock
Mar 22, 2022 08:30AM Reigo Doubles Securitization to $200 Million in Residential Bridge Loans
Mar 22, 2022 08:16AM Troika Media (TRKA) Completes Transformative Acquisition of Converge Direct LLC Adding Approximately $300 Million of Revenue and $21 Million of Net Income
Mar 22, 2022 08:00AM Troika Media Group Completes Transformative Acquisition of Converge Direct LLC Adding Approximately $300 Million of Revenue and $21 Million of Net Income
Mar 22, 2022 08:00AM Troika Media Group Completes Transformative Acquisition of Converge Direct LLC Adding Approximately $300 Million of Revenue and $21 Million of Net Income
Mar 22, 2022 08:00AM Troika Media Group Completes Transformative Acquisition of Converge Direct LLC Adding Approximately $300 Million of Revenue and $21 Million of Net Income
Mar 22, 2022 08:00AM Troika Media Group Completes Transformative Acquisition of Converge Direct LLC Adding Approximately $300 Million of Revenue and $21 Million of Net Income
Mar 22, 2022 08:00AM Aytu BioPharma to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Mar 22, 2022 07:30AM Decibel Therapeutics to Participate in Upcoming Investor Conferences
View More Recent Stories View Older Stories